Relationships Between Left Ventricular Asynchrony and Myocardial Blood Flow
Overview
Authors
Affiliations
Objective: Rb PET protocols enable determination of left ventricular asynchrony (LVAS) at rest and stress, along with myocardial blood flow (MBF). We hypothesized that in patients with resting LVAS, MBF differs between those with stress-induced LVAS improvement and those with stress-induced LVAS deterioration.
Methods: We retrospectively analyzed Rb rest/regadenoson stress PET studies of 195 patients evaluated for known or suspected coronary artery disease. MBF was computed from first-pass data; function and relative perfusion were computed from myocardial equilibrium data. LVAS was defined as phase contraction bandwidth (BW) above Rb gender-specific normal limits, with changes defined as BW moving into or out of normal ranges.
Results: Among the 195 patients, 64 had LVAS at rest, of whom 13 reverted to normal and 51 continued to have LVAS with stress. Patients who did not improve had lower stress MBF (1.04 ± 0.69 vs 1.58 ± 0.67, p = .02) and coronary flow reserve (1.94 ± 1.16 vs 3.04 ± 1.22, p = .01) than those who did improve. ROC analysis indicated that the parameter most strongly associated with improvement in asynchrony for patients with resting LVAS was reduction in MBF heterogeneity (ROC area (accuracy) = 84%, sensitivity = 92%, and specificity = 67%).
Conclusion: LVAS is highly correlated with MBF and CVR, with stress-induced improvement in synchronicity most strongly associated with improved MBF homogeneity.
Zheng D, Liu Y, Zhang L, Hu F, Tan X, Jiang D Front Cardiovasc Med. 2021; 8:719565.
PMID: 34722656 PMC: 8555411. DOI: 10.3389/fcvm.2021.719565.
Left ventricular regional asynchrony: Earliest marker for ischemic cardiomyopathy?.
Vij A, Malhotra S J Nucl Cardiol. 2020; 28(3):1051-1054.
PMID: 32901419 DOI: 10.1007/s12350-020-02355-2.
Juarez-Orozco L, Monroy-Gonzalez A, Prakken N, Noordzij W, Knuuti J, deKemp R J Nucl Cardiol. 2019; 26(6):1904-1913.
PMID: 30834496 PMC: 6908565. DOI: 10.1007/s12350-019-01670-7.
Juarez-Orozco L, Monroy-Gonzalez A, van der Zant F, Hoogvorst N, Slart R, Knol R J Nucl Cardiol. 2018; 27(6):2234-2242.
PMID: 30443751 PMC: 7749096. DOI: 10.1007/s12350-018-01507-9.
AlJaroudi W, Hage F J Nucl Cardiol. 2017; 25(1):320-330.
PMID: 29119374 DOI: 10.1007/s12350-017-1120-8.